Litcius/Paper detail

USP22-JMJD8 axis promotes Lenvatinib resistance in hepatocellular carcinoma

Jinhui Guo, Jie Zhao

2023Biochimica et Biophysica Acta (BBA) - Molecular Cell Research12 citationsDOI

Topics & Concepts

LenvatinibGene knockdownCancer researchSorafenibMedicineHepatocellular carcinomaDrug resistanceApoptosisPharmacologyBiologyMicrobiologyBiochemistryCancer, Hypoxia, and MetabolismHepatocellular Carcinoma Treatment and PrognosisUbiquitin and proteasome pathways
USP22-JMJD8 axis promotes Lenvatinib resistance in hepatocellular carcinoma | Litcius